Bullish
Connect Biopharma stock rises after Phase 2 asthma study enrollment By Investing.com
Connect Biopharma Holdings Ltd (NASDAQ: CNTB) shares rose 8% after announcing the completion of enrollment in its Phase 2 Seabreeze STAT Asthma study ...